Randomized Trial of Mosapride Versus Placebo in the Treatment of Constipation-Predominant Irritable Bowel Syndrome
Status:
Terminated
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether Mosapride, an agent which acts on serotonin
receptors in the gastrointestinal tract, is effective in the treatment of
constipation-predominant irritable bowel syndrome (C-IBS).